Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.57 USD | +1.06% | -0.70% | +0.83% |
05-14 | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.83% | 461M | |
+27.88% | 49.18B | |
+0.72% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.75% | 26.09B | |
-22.49% | 18.71B | |
+7.81% | 13.26B | |
+32.25% | 12.32B | |
-0.31% | 11.99B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Raises Voyager Therapeutics' Price Target to $10 From $4, Keeps Neutral Rating